Alexandra Hospital

At Alexandra Hospital in Athens, clinical research in cardiovascular diseases focuses on major conditions such as heart failure, atrial fibrillation, atherosclerotic cardiovascular disease, stroke, and transthyretin-mediated amyloid cardiomyopathy. The studies are aimed at improving prevention, reducing complications, and evaluating new treatment options for people at high cardiovascular risk.

• Research on heart failure is evaluating whether new therapies can lower hospitalizations and cardiovascular deaths.
• Trials in atrial fibrillation are comparing approaches to prevent stroke and systemic embolism while balancing bleeding risk.
• Studies in atherosclerotic cardiovascular disease and elevated lipoprotein(a) are exploring ways to reduce future heart attacks and urgent revascularization.
• Work in amyloid cardiomyopathy is examining longer-term safety and tolerability of treatments for this rare heart condition.

This area reflects a strong interest in both common and complex cardiac disorders, with a clear focus on prevention, symptom control, and better long-term outcomes.

The Plasma Cell Dyscrasias Unit at Alexandra Hospital supports a broad portfolio of studies in hematologic cancers and related blood disorders. Key diseases include multiple myeloma, Waldenström’s macroglobulinemia, and diffuse large B-cell lymphoma, with research also touching on other aggressive blood malignancies. The overall goal is to improve disease control and extend survival.

• Studies in multiple myeloma are testing new maintenance and combination treatment strategies for newly diagnosed and relapsed disease.
• Research in Waldenström’s macroglobulinemia is focused on patients with difficult-to-treat or previously treated disease.
• Trials in lymphoma are assessing whether adding novel therapies can improve progression-free survival.
• The site’s hematology research aims to refine treatment effectiveness while addressing safety and tolerability in blood cancers.

These studies highlight a specialized focus on plasma cell disorders and other lymphoid malignancies, combining clinical care with research on more effective cancer treatment.

The cancer research program at Alexandra Hospital spans multiple solid tumors, including breast cancer, lung cancer, endometrial cancer, prostate cancer, colon cancer, and urothelial carcinoma. Across these studies, investigators are evaluating new therapies, improving disease-free and progression-free survival, and helping define better treatment strategies for patients with advanced or high-risk disease.

• In breast cancer, trials are examining endocrine-based strategies and novel targeted treatments to reduce recurrence and slow progression.
• Lung cancer research includes studies for both non-small cell and small cell disease, with attention to difficult-to-treat molecular subtypes.
• Studies in endometrial cancer and colon cancer are testing peri-operative and adjuvant approaches to improve cure rates.
• Additional oncology work includes prostate cancer, kidney cancer, and urothelial cancer, where the aim is to improve response and delay disease worsening.

Overall, the site shows a broad commitment to oncology research, with emphasis on advanced disease, recurrence prevention, and treatment comparison across several cancer types.